过去一年中添加的文章，按日期排序
Incorporating immunotherapy in the management of early-stage estrogen receptor-positive breast cancer
G Nader-Marta, AG Waks, SM Tolaney, EL Mayer - ESMO Open, 2024 - esmoopen.com
11 天前 - … treatment regimens for patients with early and advanced triple-negative breast
cancer (TNBC… with Luminal B-like breast cancer treated with neoadjuvant chemotherapy (NACT), …
cancer (TNBC… with Luminal B-like breast cancer treated with neoadjuvant chemotherapy (NACT), …
667 Phase 1 study of intratumoral administration of VAX014 in subjects with advanced solid tumors
EI Buchbinder, RM Weight, P Chalasani, ED Whitman… - 2024 - jitc.bmj.com
11 天前 - … Results As of 27-June-2024, four subjects (melanoma [n=3], triple negative breast
cancer [n=1] have received weekly intratumoral injections of VAX014 across 2 dose cohorts …
cancer [n=1] have received weekly intratumoral injections of VAX014 across 2 dose cohorts …
387 Identification of novel T cell receptor (TCR) target to brachyury for the development of T cell-based immunotherapy of chordoma and other solid tumors
11 天前 - Background Brachyury (TBXT) is extensively expressed in chordoma (a refractory
rare bone cancer), as well as solid tumors such as lung and breast cancer. The aim of this …
rare bone cancer), as well as solid tumors such as lung and breast cancer. The aim of this …
1392 Immune infiltration is associated with improved survival in primary, advanced-stage p53-abnormal endometrial carcinoma
11 天前 - Background Our group and others previously demonstrated that endometrial
carcinoma (EC) is comprised of four molecular subtypes that are biologically distinct, …
carcinoma (EC) is comprised of four molecular subtypes that are biologically distinct, …
[HTML][HTML] 288 Targeting B7H3-driven tumor growth with CAR-T cell therapy in mouse models of obesity and triple negative breast cancer
H Malian, M Coleman, CM Pellegry, A Ho, E Glenny… - 2024 - jitc.bmj.com
11 天前 - … models of obesity and triple negative breast cancer | Journal for ImmunoTherapy
of … Triple negative breast cancer (TNBC) is one of the most difficult to treat breast cancer …
of … Triple negative breast cancer (TNBC) is one of the most difficult to treat breast cancer …
[HTML][HTML] 487 The SIRPα myeloid checkpoint regulates the functional differentiation of conventional dendritic cells type 3 (cDC3) in the tumor microenvironment
11 天前 - … (RT), to promote an in-situ vaccination and enhance tumor responses to
immunotherapy… triple negative (AT3) breast cancer. MY1 monotherapy did not affect TSA or AT3 …
immunotherapy… triple negative (AT3) breast cancer. MY1 monotherapy did not affect TSA or AT3 …
555 Anti-tumor activity of Treg-depleting therapy depending on the tumor glycolytic capacity
JH Kang, I Serganova, PC Ho, A Schreier, V Stearns… - 2024 - jitc.bmj.com
11 天前 - … These findings demonstrated that Tregs are a key element of immunotherapy …
triple negative breast cancer 4T1 and melanoma B16.We orthotopically implanted these tumor …
triple negative breast cancer 4T1 and melanoma B16.We orthotopically implanted these tumor …
[HTML][HTML] … Serum analytes associate with clinical outcomes in patients with triple negative breast cancer enrolled in the OXEL trial treated with nivolumab, capecitabine …
NJ Toney, MT Lynch, F Lynce, C Mainor, C Isaacs… - 2024 - jitc.bmj.com
11 天前 - … II trial for patients with triple negative breast cancer (TNBC) and … immunotherapy
(nivolumab, Arm A), chemotherapy (capecitabine, Arm B), or the combination of immunotherapy …
(nivolumab, Arm A), chemotherapy (capecitabine, Arm B), or the combination of immunotherapy …
1359 A tumor metabolism-angiogenesis-immune axis impacts the response to cancer immunotherapy
11 天前 - … immunotherapy. Methods We used metabolic variants of the murine triple negative
breast cancer … by low-dose ethidium bromide treatment to eliminate mitochondrial DNA (Rho0…
breast cancer … by low-dose ethidium bromide treatment to eliminate mitochondrial DNA (Rho0…
[HTML][HTML] … of dazostinag plus pembrolizumab after hypofractionated radiotherapy in patients with non-small-cell lung cancer, triple-negative breast cancer, or head and …
11 天前 - … synergistic efficacy of combining dazostinag plus pembrolizumab (dazo+pembro)
after … 8Gy ×3 fractions of image-guided radiation followed (≥40h) by pembrolizumab 200 mg …
after … 8Gy ×3 fractions of image-guided radiation followed (≥40h) by pembrolizumab 200 mg …